您好,欢迎来到化工原料网! [登录] [免费注册]
化工原料网
位置:首页 > 产品库 > Trimipramine-d3(maleate)
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
Trimipramine-d3(maleate)
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
Trimipramine-d3(maleate)图片
规格:98%
分子量:413.5
包装与价格:
包装价格(元)
500ug电议
1mg电议
5mg电议

产品介绍
C20H23D3N2•C4H4O4
货号:ajcx24260
CAS:N/A
分子式:C20H23D3N2•C4H4O4
分子量:413.5
溶解度:DMSO: soluble,Methanol: soluble
纯度:98%
存储:Store at -20°C
库存:现货

Background:

Trimipramine-d3(maleate) is intended for use as an internal standard for the quantification of trimipramine (maleate) by GC- or LC-MS. Trimipramine is a tricyclic antidepressant.1,2,3It selectively binds the serotonin (5-HT) transporter (SERT) over the norepinephrine transporter (NET) and dopamine transporter (DAT; Kds = 149, 2,450, and 3,780 nM, respectively) and acts as a histamine H1receptor antagonist (Ki= 0.02 µM) that is selective for histamine H1over H2, H3, and H4receptors (Kis = 0.04, >100, and 43.6 µM, respectively).1,2Trimipramine binds to muscarinic acetylcholine and α1- and α2-adrenergic receptors (Kds = 58, 24, and 580 nM, respectively), as well as dopamine D1and D2receptors and 5-HT receptor subtypes 5-HT1Cand 5-HT2(Kis = 346.7, 57.5, 537, and 19.5 nM, respectively).1,3It reduces immobility time in the forced swim test in rats when administered at a dose of 10 mg/kg.4Formulations containing trimipramine have previously been used in the treatment of depression.


1.Richelson, E., and Nelson, A.Antagonism by antidepressants of neurotransmitter receptors of normal human brain in vitroJ. Pharmacol. Exp. Ther.230(1)94-102(1984) 2.Appl, H., Holzammer, T., Dove, S., et al.Interactions of recombinant human histamine H1, H2, H3, and H4 receptors with 34 antidepressants and antipsychoticsNaunyn-Schmiedebergs Arch. Pharmacol.385(2)145-170(2012) 3.Gross, G., Xin, X., and Gastpar, M.Trimipramine: Pharmacological reevaluation and comparison with clozapineNeuropharmacology30(11)1159-1166(1991) 4.Delini-Stula, A., Radeke, E., and van Riezen, H.Enhanced functional responsiveness of the dopaminergic system-the mechanism of anti-immobility effects of antidepressants in the behavioural despair test in the ratNeuropharmacology27(9)943-947(1988)